The novel and versatile metal nanomedicines with GSH-responsive and -exhausted capability are highly desirable for continuous advance in anticancer research, and this strategy will find more clinical applications in the future
If you are someone who has dealt with diarrhea from tirzepatide , the experience will feel familiar, though typically less severe
Spekang to investors at the companys Q3 FY26 earnings call earlier this month, Patel said that, we will also out-license it to two to three other companies, who will market their formulations in the country. Alongside Zydus, Sun Pharma and Alkem Laboratories have also secured approval for both type-2 diabetes and weight management, while their Hyderabad-peers NATCO and Dr Reddys currently hold approval only for the type 2 diabetes indication.
If left untreated, it can advance to liver fibrosis, cirrhosis, and liver failure
In general, the industry continues to be in a healthy position and future forecasts are promising, according to Mr